05/13/2025
10:18 AM | Halozyme Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
05/02/2025
3:04 PM | Duncan Barbara Gayle (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
3:06 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
3:07 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
3:08 PM | Halozyme Therapeutics (Issuer)
Krishnan Mahesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
5:04 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
4:18 PM | BlackRock, Inc. (Filed by)
Halozyme Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/01/2025
5:32 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:17 PM | Halozyme Therapeutics (Filer)
| Form ARS | |
03/18/2025
3:10 PM | Halozyme Therapeutics (Filer)
| Form DEF 14A | |
03/03/2025
7:46 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for HALO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/27/2025
5:32 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
3:32 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
4:07 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:11 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:49 PM | Halozyme Therapeutics (Issuer)
LaBrosse Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:50 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:52 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:47 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:37 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:39 PM | Halozyme Therapeutics (Issuer)
LaBrosse Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:41 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:12 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:08 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:09 PM | Halozyme Therapeutics (Issuer)
LaBrosse Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:11 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
5:07 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:21 PM | Halozyme Therapeutics (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:00 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:14 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:12 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:26 PM | Halozyme Therapeutics (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
8:36 AM | Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
| Form SC 13G/A | |
10/31/2024
3:05 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
8:36 AM | Halozyme Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
10/16/2024
5:53 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:14 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:34 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
4:39 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:09 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:08 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad) tock Market Panic: Trump Just Dropped a Bomb on Your Stocks
The market is in freefall—and Trump's new tariffs just lit the fuse.
Millions of investors are blindsided as stocks plunge… but this is only Phase 1.
If you're still holding the wrong assets, you could lose 30% or more in the coming weeks. Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow |
09/26/2024
5:06 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:00 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/24/2024
3:05 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
5:49 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:01 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
4:56 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:12 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:05 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:16 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
6:49 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:03 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:16 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
3:59 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:31 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:19 PM | Halozyme Therapeutics (Subject)
Torley Helen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:41 PM | Halozyme Therapeutics (Subject)
Posard Matthew L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:48 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:05 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:11 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
3:13 PM | Halozyme Therapeutics (Subject)
LaBrosse Nicole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
3:51 PM | Halozyme Therapeutics (Subject)
LaBrosse Nicole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2024
3:29 PM | Halozyme Therapeutics (Subject)
LaBrosse Nicole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
3:16 PM | Halozyme Therapeutics (Subject)
LaBrosse Nicole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:17 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:22 PM | Halozyme Therapeutics (Subject)
LaBarre Michael J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:17 PM | Halozyme Therapeutics (Issuer)
Snyder Mark Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:40 PM | Halozyme Therapeutics (Subject)
Posard Matthew L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
4:24 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy HALO Stock Free HALO Stock Alerts